Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 1/20 | 0.56 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.55 |
| ▸ | ERAP2 | Q6P179 | 4/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | CASP4 | P49662 | 1/20 | 0.52 |
| ▸ | CASP5 | P51878 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 1/20 | 0.52 |
| ▸ | CASP9 | P55211 | 1/20 | 0.52 |
| ▸ | CASP6 | P55212 | 1/20 | 0.52 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.52 |
| ▸ | CASP10 | Q92851 | 1/20 | 0.52 |
| ▸ | NPBWR1 | P48145 | 3/20 | 0.51 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.50 |
| ▸ | CTSK | P43235 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | GRPR | P30550 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31388252 | 0.92 | MAGI3 (0.59) | EDNRAMAGI3CASP1CASP3CASP4 | |
| SCHEMBL30219058 | 0.88 | ERAP2 (0.60) | ERAP2NPBWR1KISS1ROPRM1OPRD1 | |
| SCHEMBL31099263 | 0.88 | GLP1R (0.63) | NPBWR1RXFP1 | |
| SCHEMBL29634675 | 0.88 | GLP1R (0.63) | NPBWR1RXFP1 | |
| SCHEMBL30918508 | 0.87 | GLP1R (0.59) | — | |
| SCHEMBL30571040 | 0.86 | OPRM1 (0.57) | EDNRAMAGI3ERAP2CASP1CASP3 | |
| SCHEMBL29359346 | 0.85 | ERAP2 (0.57) | EDNRAMAGI3ERAP2CASP1CASP3 | |
| SCHEMBL30721568 | 0.85 | EDNRA (0.60) | EDNRAMAGI3ERAP2CASP1CASP3 | |
| SCHEMBL30874380 | 0.85 | EDNRA (0.58) | EDNRAMAGI3ERAP2KISS1RCTSB | |
| SCHEMBL31442259 | 0.85 | EDNRA (0.61) | EDNRAMAGI3ERAP2CTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250019410-A1 | PROCESS FOR THE PREPARATION OF TIRZEPATIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2025-01-16 | — | — | US | disclosed |
| CN-119161413-A | Preparation method of high-purity hydrogel polypeptide | 杭州湃肽生化科技有限公司 | 2024-12-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250019410-A1 | PROCESS FOR THE PREPARATION OF TIRZEPATIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | SYK, TREH, QDPR | EDNRA 2141/4885MAGI3 2014/4885ERAP2 1695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.